Molecular determinants of orexin receptor-arrestinubiquitin complex formation

por Jaeger, Werner C, Seeber, Ruth M, Eidne, Karin A, Pfleger, Kevin DG
Publicado 2014

Enhanced BRET Technology for the Monitoring of Agonist-Induced and Agonist-Independent Interactions between GPCRs and β-Arrestins

por Kocan, Martina, Dalrymple, Matthew B., Seeber, Ruth M., Feldman, Brian J., Pfleger, Kevin D. G.
Publicado 2011

Profiling Epidermal Growth Factor Receptor and Heregulin Receptor 3 Heteromerization Using Receptor Tyrosine Kinase Heteromer Investigation Technology

por Ayoub, Mohammed Akli, See, Heng B., Seeber, Ruth M., Armstrong, Stephen P., Pfleger, Kevin D. G.
Publicado 2013

Characterization of Three Vasopressin Receptor 2 Variants: An Apparent Polymorphism (V266A) and Two Loss-of-Function Mutations (R181C and M311V)

por Armstrong, Stephen P., Seeber, Ruth M., Ayoub, Mohammed Akli, Feldman, Brian J., Pfleger, Kevin D. G.
Publicado 2013

Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor

por Johnstone, Elizabeth K. M., Ayoub, Mohammed Akli, Hertzman, Rebecca J., See, Heng B., Abhayawardana, Rekhati S., Seeber, Ruth M., Pfleger, Kevin D. G.
Publicado 2022

Identification and Profiling of Novel α(1A)-Adrenoceptor-CXC Chemokine Receptor 2 Heteromer

por Mustafa, Sanam, See, Heng B., Seeber, Ruth M., Armstrong, Stephen P., White, Carl W., Ventura, Sabatino, Ayoub, Mohammed Akli, Pfleger, Kevin D. G.
Publicado 2012

Mutations of Vasopressin Receptor 2 Including Novel L312S Have Differential Effects on Trafficking

por Tiulpakov, Anatoly, White, Carl W., Abhayawardana, Rekhati S., See, Heng B., Chan, Audrey S., Seeber, Ruth M., Heng, Julian I., Dedov, Ivan, Pavlos, Nathan J., Pfleger, Kevin D. G.
Publicado 2016